These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 28883271)

  • 1. [Picture in Clinical Hematology No. 106].
    Rinsho Ketsueki; 2017; 58(8):903. PubMed ID: 28883271
    [No Abstract]   [Full Text] [Related]  

  • 2. Change of initial staging at early remission evaluation with FDG-PET/CT in Hodgkin lymphoma: a report of two cases.
    Molin D; Hagberg H; Suurküla M; Aström G
    Acta Oncol; 2010 May; 49(4):526-8. PubMed ID: 20397779
    [No Abstract]   [Full Text] [Related]  

  • 3. Impact of bone marrow involvement on early positron emission tomography response and progression-free survival in the HD18 trial for patients with advanced-stage Hodgkin lymphoma.
    Kreissl S; Voltin CA; Kaul H; Bühnen I; Mettler J; Pabst T; Eichenauer DA; Fuchs M; Diehl V; Dietlein M; Engert A; Borchmann P; Kobe C
    Br J Haematol; 2022 Apr; 197(1):e5-e8. PubMed ID: 34929056
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence of a graft-versus-Hodgkin lymphoma effect in the setting of extensive bone marrow involvement.
    Anderlini P; Swanston N; Rashid A; Bueso-Ramos C; Macapinlac HA; Champlin RE
    Biol Blood Marrow Transplant; 2008 Apr; 14(4):478-80. PubMed ID: 18342791
    [No Abstract]   [Full Text] [Related]  

  • 5. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?
    Çetin G; Çıkrıkçıoğlu MA; Özkan T; Karatoprak C; Ar MC; Eşkazan AE; Ayer M; Cerit A; Gözübenli K; Uysal BB; Erdem S; Ergül N; Tatar G; Çermik TF
    Turk J Haematol; 2015 Sep; 32(3):213-9. PubMed ID: 25912844
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Report of satellite workshop on interim-PET in Hodgkin lymphoma: 8th International Symposium on Hodgkin Lymphoma, Cologne, 23 October 2010.
    Gallamini A; O'Doherty M
    Leuk Lymphoma; 2011 Apr; 52(4):583-6. PubMed ID: 21438829
    [No Abstract]   [Full Text] [Related]  

  • 7. [Evaluation of bone marrow involvement by FDG-PET for refractory Hodgkin lymphoma treated by unrelated allogeneic bone marrow transplantation].
    Toubai T; Ota S; Onodera M; Baba U; Fujisawa F; Miura Y; Toyoshima N; Tanaka J; Asaka M; Imamura M
    Rinsho Ketsueki; 2003 Jul; 44(7):446-50. PubMed ID: 12931562
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical course and treatment of Hodgkin's disease with concomitant bone marrow lesions].
    Gershanovich ML; Kanaev SV; Filatova LV; Novikov SN; Leenman EE; Pozharisskiĭ KM
    Vopr Onkol; 2002; 48(1):29-36. PubMed ID: 12101562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lennert's lymphoma].
    Osorio G; Rosenberg D
    Rev Med Chil; 1984 Jun; 112(6):582-5. PubMed ID: 6515172
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary lymphocyte-rich classical Hodgkin lymphoma with early response to ABVD therapy.
    Honda A; Nakamura F; Nannya Y; Shintani Y; Fukayama M; Ichikawa M; Kurokawa M
    Ann Hematol; 2014 Jun; 93(6):1073-4. PubMed ID: 24173088
    [No Abstract]   [Full Text] [Related]  

  • 11. Failure of fluorodeoxyglucose positron emission tomography to detect the high-grade transformation of nodular lymphocyte predominant Hodgkin's lymphoma.
    Puyade M; Yacoub M; Tomowiak C; Diviné M; Perdrisot R; Guilhot F; Delwail V
    Acta Haematol; 2013; 129(4):229-31. PubMed ID: 23328622
    [No Abstract]   [Full Text] [Related]  

  • 12. Bone marrow signal during PET imaging in Hodgkin lymphoma.
    Fyfe A; McKay P; Leach M
    Br J Haematol; 2010 Apr; 149(2):165. PubMed ID: 20015301
    [No Abstract]   [Full Text] [Related]  

  • 13. Diffusion-weighted MRI compared to FDG PET-CT in the staging and response assessment of Hodgkin lymphoma.
    Marzolini M; Wong WL; Ardeshna K; Padhani A; D'Sa S
    Br J Haematol; 2012 Mar; 156(5):557. PubMed ID: 22150023
    [No Abstract]   [Full Text] [Related]  

  • 14. Cryptococcosis in bone marrow following treatment for Hodgkin lymphoma.
    Yigit N; Wu WW; Covey S; Tam W
    Int J Hematol; 2015 Mar; 101(3):211-2. PubMed ID: 25552246
    [No Abstract]   [Full Text] [Related]  

  • 15. T-cell/histiocyte-rich large B-cell lymphoma--transformation of nodular lymphocyte predominant Hodgkin lymphoma in the bone marrow.
    Eyre TA; King AJ; Hatton C; Collins GP
    Eur J Haematol; 2014 Jun; 92(6):550-1. PubMed ID: 24483596
    [No Abstract]   [Full Text] [Related]  

  • 16.
    Hassan A; Siddique M; Bashir H; Riaz S; Wali R; Mahreen A; Nawaz MK
    Eur J Nucl Med Mol Imaging; 2017 Jul; 44(7):1198-1206. PubMed ID: 28229191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An unknown pregnancy at term detected by a FDG-PET/CT study in a patient with Hodgkin's lymphoma: A case report.
    Erdogan EB; Ekmekcioglu O; Vatankulu B; Ergül N; Demir M; Sonmezoglu K
    Rev Esp Med Nucl Imagen Mol; 2015; 34(3):201-2. PubMed ID: 25153018
    [No Abstract]   [Full Text] [Related]  

  • 18. Meeting highlights 46th annual meeting of the American Society of Hematology December 2004 San Diego, California.
    Price N; Reddy GK; Jain VK
    Clin Lymphoma; 2004 Dec; 5(3):144-8. PubMed ID: 15636687
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of Hodgkin lymphoma in a patient with sarcoidosis.
    Gediz F; Yilmaz AF; Payzin B; Yuksel T; Calli AO; Kobak S
    Reumatismo; 2017 Aug; 69(2):84-87. PubMed ID: 28776363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodular sclerosing Hodgkin disease presenting as a sternal mass.
    Priola SM; Priola AM; Cataldi A; Fava C
    Br J Haematol; 2006 Dec; 135(5):594. PubMed ID: 17107345
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.